 |
Articles: General Pharma |
Inno Biologics and CEVEC Sign License Agreement for Human CAP Technology
b3c newswire, 12/09/09
Trends in hypertension treatment in diabetes
Current Hypertension Reports, 12/09/09 Medtronic Hires Renowned Cardiologist as Vice President of Medical Affairs for Coronary and Peripheral Business
Medtronic, 12/09/09
Free full text
Federal Advisory Committees to Meet
HealthDataManagement, 12/09/09 Quality by Design for Biotechnology Products—Part 2
BioPharm, 12/09/09
Free full text
Robert J. Bertolini Elected to Genzyme's Board of Directors
Genzyme, 12/09/09
Free full text
The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury
Trials, 12/09/09
Free full text
Mylan Announces Settlement Agreement Related to Antidepressant Effexor XR
Mylan, 12/09/09 Freeze-Thaw Performance and Robustness Assessment of Celsius FFT 6L
BioPharm, 12/09/09
Free full text
Umbilical vein oxytocin for the treatment of retained placenta (Release Study): a double-blind, randomised controlled trial
The Lancet - Early Online Publication, 12/09/09 Bivariate Random Effects Meta-Analysis of Diagnostic Studies Using Generalized Linear Mixed Models
Medical Decision Making, 12/09/09 The Impact of Disposables on Project Economics in a New Antibody Plant
BioPharm, 12/09/09
Free full text
AstraZeneca Medicare Part D patient assistance program no longer requires co-pays
AstraZeneca, 12/09/09
Free full text
Astellas Inducted into National Minority Transplant Hall of Fame
Astellas, 12/09/09
Free full text
MabThera/Rituxan is the first treatment to show improved overall survival in previously untreated patients with chronic lymphocytic leukemia
Roche, 12/09/09
Free full text
Allos Therapeutics' FOLOTYN Shows Activity in a Dose Finding Phase 1 Study of Relapsed or Refractory Cutaneous T-Cell Lymphoma
Allos Therapeutics, 12/09/09
Free full text
Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation
PhRMA, 12/09/09
Free full text
Amylin Pharmaceuticals to Present at the 2009 Deutsche Bank Biotech Boston Confab
Amylin Pharmaceuticals, 12/09/09
Free full text
Inability of Pixantrone to Form Toxic Iron Complexes Results in Significant Reduction in Cardiac Cell Toxicity Compared to Currently Marketed Anthracyclines
Cell Therapeutics, 12/09/09
Free full text
Novartis Tasigna trial shows superior results to Glivec in patients with early-stage chronic myeloid leukemia
Novartis, 12/09/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
|
|
